Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Emmerich

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Blut|February 1, 1982
[Fibroblast interferon therapy in patients with NHL of low-grade malignancy: preliminary results (author's transl)]U Fink, W Siegert, D Huhn, et al.
British Journal of Haematology|August 1, 1996
Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre studyI Langenmayer, C Nerl, W Knauf, et al.
Leukemia|May 15, 2007
A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cellsM Schwemmlein, J Stieglmaier, C Kellner, et al.
Gene Therapy|July 1, 1997
Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell responseC M Wendtner, A Nolte, E Mangold, et al.
Experimental Hematology|December 24, 1997
Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell linesM Hallek, C Neumann, M Schäffer, et al.
Anticancer Research|July 1, 1982
Treatment of non-hodgkin's lymphoma of low-grade malignancy with human fibroblast interferonW Siegert, H Theml, U Fink, et al.
Annals of Hematology|January 27, 2000
Second malignancies after Hodgkin's disease: the Munich experienceR Munker, S Grützner, E Hiller, et al.
Blood|August 25, 2001
Rituximab therapy of patients with B-cell chronic lymphocytic leukemiaD Huhn, C von Schilling, M Wilhelm, et al.
Cancers|September 28, 2024
Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal CancersRuchi Shah, Katherine A Johnson, Anna E L Lippert, et al.
Der Internist|January 15, 2003
[Chronic lymphatic leukemia. Current therapy concepts]M Hallek, M Bergmann, G Brittinger, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Blut|February 1, 1982
[Fibroblast interferon therapy in patients with NHL of low-grade malignancy: preliminary results (author's transl)]U Fink, W Siegert, D Huhn, et al.
British Journal of Haematology|August 1, 1996
Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre studyI Langenmayer, C Nerl, W Knauf, et al.
Leukemia|May 15, 2007
A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cellsM Schwemmlein, J Stieglmaier, C Kellner, et al.
Gene Therapy|July 1, 1997
Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell responseC M Wendtner, A Nolte, E Mangold, et al.
Experimental Hematology|December 24, 1997
Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell linesM Hallek, C Neumann, M Schäffer, et al.
Anticancer Research|July 1, 1982
Treatment of non-hodgkin's lymphoma of low-grade malignancy with human fibroblast interferonW Siegert, H Theml, U Fink, et al.
Annals of Hematology|January 27, 2000
Second malignancies after Hodgkin's disease: the Munich experienceR Munker, S Grützner, E Hiller, et al.
Blood|August 25, 2001
Rituximab therapy of patients with B-cell chronic lymphocytic leukemiaD Huhn, C von Schilling, M Wilhelm, et al.
Cancers|September 28, 2024
Cancer-Associated Fibroblast Proteins as Potential Targets against Colorectal CancersRuchi Shah, Katherine A Johnson, Anna E L Lippert, et al.
Der Internist|January 15, 2003
[Chronic lymphatic leukemia. Current therapy concepts]M Hallek, M Bergmann, G Brittinger, et al.
Pageof 15